[
  {
    "ts": null,
    "headline": "Zoetis (ZTS) Falls Following Q3 Disappointment and Librela Demand Weakness",
    "summary": "Impax Asset Management‘s “Impax US Sustainable Economy Fund” released its Q4 2025 investor letter. A copy of the letter can be downloaded here. The fund reported that equity markets remained volatile during the quarter amid concerns over elevated valuations and financing for large-scale data center investments, although the portfolio modestly outperformed the Russell 1000 benchmark […]",
    "url": "https://finnhub.io/api/news?id=df95a69a37ca3c121aa36d620d1f5e472d9543cc472d10048ccc7e8a55717115",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771427104,
      "headline": "Zoetis (ZTS) Falls Following Q3 Disappointment and Librela Demand Weakness",
      "id": 139136765,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "Impax Asset Management‘s “Impax US Sustainable Economy Fund” released its Q4 2025 investor letter. A copy of the letter can be downloaded here. The fund reported that equity markets remained volatile during the quarter amid concerns over elevated valuations and financing for large-scale data center investments, although the portfolio modestly outperformed the Russell 1000 benchmark […]",
      "url": "https://finnhub.io/api/news?id=df95a69a37ca3c121aa36d620d1f5e472d9543cc472d10048ccc7e8a55717115"
    }
  },
  {
    "ts": null,
    "headline": "Bank of America Cites Zoetis Inc.’s (ZTS) Strong Q4 Performance and Fiscal 2026 Outlook",
    "summary": "Zoetis Inc. (NYSE:ZTS) is among the 7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds. Zoetis Inc. (NYSE:ZTS) tops our list for being one of the cheap pharmaceutical stocks. TheFly reported on February 13 that Bank of America raised its price target for ZTS to $140 from $135 and maintained a Neutral rating on the shares. The upgraded […]",
    "url": "https://finnhub.io/api/news?id=38d2f107b2f250f0bcae94e4756c1c0135d5db5a19ad7517400a705737522952",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771405304,
      "headline": "Bank of America Cites Zoetis Inc.’s (ZTS) Strong Q4 Performance and Fiscal 2026 Outlook",
      "id": 139131588,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "Zoetis Inc. (NYSE:ZTS) is among the 7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds. Zoetis Inc. (NYSE:ZTS) tops our list for being one of the cheap pharmaceutical stocks. TheFly reported on February 13 that Bank of America raised its price target for ZTS to $140 from $135 and maintained a Neutral rating on the shares. The upgraded […]",
      "url": "https://finnhub.io/api/news?id=38d2f107b2f250f0bcae94e4756c1c0135d5db5a19ad7517400a705737522952"
    }
  }
]